Clinical Trials
Avutometinib + Sotorasib in Patients with KRAS G12C mutant NSCLC
Disease Type: Lung
A Phase 1/2 Study of Avutometinib (VS-6766) in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) (VS-6766-203)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville